about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More
1.36
-0.09
(-6.21%)
1.2M
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Cabaletta Bio Inc took place on 08 Aug 2025, for the purpose of Cabaletta Bio Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..